10-94775507-G-A
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBP6_StrongBS2
The NM_000769.4(CYP2C19):c.449G>A(p.Arg150His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00498 in 1,613,980 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as drug response (★★★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_000769.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYP2C19 | NM_000769.4 | c.449G>A | p.Arg150His | missense_variant | 3/9 | ENST00000371321.9 | NP_000760.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYP2C19 | ENST00000371321.9 | c.449G>A | p.Arg150His | missense_variant | 3/9 | 1 | NM_000769.4 | ENSP00000360372 | P1 | |
CYP2C19 | ENST00000480405.2 | c.449G>A | p.Arg150His | missense_variant | 3/3 | 1 | ENSP00000483847 | |||
CYP2C19 | ENST00000645461.1 | n.1502G>A | non_coding_transcript_exon_variant | 2/7 |
Frequencies
GnomAD3 genomes AF: 0.00289 AC: 439AN: 152134Hom.: 5 Cov.: 32
GnomAD3 exomes AF: 0.00269 AC: 676AN: 251362Hom.: 4 AF XY: 0.00277 AC XY: 376AN XY: 135848
GnomAD4 exome AF: 0.00520 AC: 7604AN: 1461728Hom.: 26 Cov.: 31 AF XY: 0.00501 AC XY: 3645AN XY: 727166
GnomAD4 genome AF: 0.00289 AC: 440AN: 152252Hom.: 5 Cov.: 32 AF XY: 0.00259 AC XY: 193AN XY: 74438
ClinVar
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2024 | CYP2C19: BP4, BS2 - |
CYP2C19: normal function Other:1
drug response, practice guideline | curation | Clinical Pharmacogenetics Implementation Consortium | - | - Allele function |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at